Guardant Health Director Sells $159K in Stock, Receives New Equity Grants

Rhea-AI Filing Summary

Director Tariq Musa of Guardant Health reported multiple transactions on June 18, 2025:

• Sale: Disposed of 3,213 shares of common stock at $49.47 per share, retaining 7,190 shares after the transaction
• Stock Options: Received 6,833 stock options with exercise price of $50.57, expiring June 18, 2035
• RSUs: Granted 4,203 restricted stock units

Both the stock options and RSUs vest in full on the earlier of June 18, 2026, or the date of the next annual stockholders meeting. This filing represents standard equity compensation for a board member, with a simultaneous sale of existing shares. The transaction was executed through an attorney-in-fact, John G. Saia.

Positive

• Director received new equity compensation with 6,833 stock options at $50.57 strike price and 4,203 RSUs, aligning long-term interests with shareholders

Negative

• Director Tariq Musa sold 3,213 shares at $49.47, reducing direct holdings to 7,190 shares

Insider Trade Summary

Net Seller: 3,213 shares

Net Sell 3 txns

Insider Tariq Musa

Role Director

Sold 3,213 shs ($159K)

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	6,833	$0.00	$0.00
Grant/Award	Restricted Stock Units	4,203	$0.00	$0.00
Sale	Common Stock	3,213	$49.47	$159K

Holdings After Transaction: Stock Option (Right to Buy) — 6,833 contracts (Direct); Restricted Stock Units — 4,203 contracts (Direct); Common Stock — 7,190 shares (Direct)

Footnotes (3)

1. F1. The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.
2. F2. The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.
3. F3. Not applicable for Restricted Stock Units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider trading activity occurred at Guardant Health (GH) on June 18, 2025?

On June 18, 2025, Director Tariq Musa sold 3,213 shares of GH common stock at $49.47 per share. Additionally, Musa was granted 6,833 stock options with an exercise price of $50.57 and 4,203 Restricted Stock Units (RSUs).

How many shares does Tariq Musa own after the recent GH stock transaction?

Following the reported transactions, Tariq Musa directly owns 7,190 shares of Guardant Health (GH) common stock, 6,833 stock options, and 4,203 Restricted Stock Units.

What are the vesting terms for GH's new stock options granted to Tariq Musa?

The stock options granted on June 18, 2025, will vest in full on the one-year anniversary of the grant date (June 18, 2025) or the date of the next year annual stockholders meeting, whichever occurs earlier. The options have an expiration date of June 18, 2035.

When do Tariq Musa's new Guardant Health (GH) RSUs vest?

The 4,203 Restricted Stock Units (RSUs) granted on June 18, 2025, will vest in full on the one-year anniversary of the grant date (June 18, 2025) or the date of the next year annual stockholders meeting, whichever occurs earlier.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/20/2025 - 05:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tariq Musa

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CA 94304

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		S		3,213	D	$49.47	7,190	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$50.57	06/18/2025		A		6,833		(1)	06/18/2035	Common Stock	6,833	$0	6,833	D
Restricted Stock Units	$0	06/18/2025		A		4,203		(2)	(3)	Common Stock	4,203	$0	4,203	D

Explanation of Responses:

1. The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.

2. The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.

3. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Musa Tariq	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.